Scientists from St. Jude Children’s Research Hospital have created an LCK targeted PROTAC, demonstrating its enhanced ability to kill...

Children who suffer a relapse of the aggressive cancer known as neuroblastoma have small chances of survival. However, a researchers...

Newly published research carried out using synthetic human bone marrow cells is paving the way for the development of safer and kinder...

Neuroblastoma, a childhood cancer that develops from neural cells on the adrenal glands, accounts for 15% of childhood cancer deaths....

Pushed by parent activists and buoyed by new funding, scientists explore novel strategies to treat deadly pediatric cancers. Read more:...

Recent study findings demonstrated that childhood cancer survivors have a significantly increased risk of being hospitalized with an ...

New research has demonstrated that a novel targeted therapy could be an effective treatment option for a deadly pediatric cancer known...

A gene that UVA Health researchers discovered is responsible for the deadliest type of brain tumor is also responsible for two forms of...

Patients with early-stage classic Hodgkin lymphoma and other neoplasms exhibited higher risk for cardiovascular disease-associated...

When it comes to treatment for cancer, and many chronic conditions in children, it often takes much longer to get new drugs and therapies...